Lufax Q3 2024 Earnings Massive EPS Miss Highlights Persistent Headwinds QUAD Q1 2026 Earnings EPS Beats Estimates by 14 Stock Climbs Marginally PEBK Q4 2025 Earnings Solid EPS of 121 Stock Declines on Limited Guidance Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations MAXN Q4 2024 Earnings Massive EPS Beat as Loss Narrower Than Expected ACNT Q1 2025 Earnings EPS Misses Estimates Amid Market Challenges